Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1)
Keywords: دارودرمانی; Schizophrenia; Drug therapy; Antipsychotic agents; Adverse effects